Survival Analysis with Correlated Endpoints - Takeshi Emura, Shigeyuki Matsui, Virginie Rondeau

Survival Analysis with Correlated Endpoints

Joint Frailty-Copula Models
Buch | Softcover
118 Seiten
2019 | 1st ed. 2019
Springer Verlag, Singapore
978-981-13-3515-0 (ISBN)
64,19 inkl. MwSt
This book introduces readers to advanced statistical methods for analyzing survival data involving correlated endpoints. Hence, the book offers an essential reference guide for medical statisticians and provides researchers with advanced, innovative statistical tools.
This book introduces readers to advanced statistical methods for analyzing survival data involving correlated endpoints. In particular, it describes statistical methods for applying Cox regression to two correlated endpoints by accounting for dependence between the endpoints with the aid of copulas. The practical advantages of employing copula-based models in medical research are explained on the basis of case studies.



In addition, the book focuses on clustered survival data, especially data arising from meta-analysis and multicenter analysis. Consequently, the statistical approaches presented here employ a frailty term for heterogeneity modeling. This brings the joint frailty-copula model, which incorporates a frailty term and a copula, into a statistical model. The book also discusses advanced techniques for dealing with high-dimensional gene expressions and developing personalized dynamic prediction tools under the joint frailty-copula model.



To help readers apply the statistical methods to real-world data, the book provides case studies using the authors’ original R software package (freely available in CRAN). The emphasis is on clinical survival data, involving time-to-tumor progression and overall survival, collected on cancer patients. Hence, the book offers an essential reference guide for medical statisticians and provides researchers with advanced, innovative statistical tools. The book also provides a concise introduction to basic multivariate survival models.

Takeshi Emura, Chang Gung University Shigeyuki Matsui, Department of Biostatistics, Nagoya University Graduate School of Medicine  Virginie Rondeau, INSERM U 1219

Chapter 1: Setting the scene.-1.1 Endpoints.- 1.2 Benefits of investigating correlated endpoints.- 1.3 Copulas and frailty: a brief history.- References.- Chapter 2: Introduction to survival analysis .-2.1 Endpoint and censoring.- 2.2 Kaplan-Meier estimator and survival function.- 2.3 Hazard function.- 2.4 Log-rank test for two-sample comparison.- 2.5 Cox regression.- 2.6 Example of Cox regression.- 2.7 Likelihood inference under non-informative censoring.- 2.8 Theoretical notes.- 2.9 Exercises.- References.- Chapter 3: The joint frailty-copula model for correlated endpoints.- 3.1 Introduction.- 3.2 Semi-competing risks data.- 3.3 Joint frailty-copula model.- 3.4 Penalized likelihood with splines.- 3.5 Case study: ovarian cancer data.- 3.6 Technical note 1: Numerical maximization of the penalized likelihood.- 3.7 Technical note 2: LCV and choice of   and  .- 3.8 Exercises.- References.- Chapter 4: High-dimensional covariates in the joint frailty-copula model.- 4.1 Introduction.- 4.2 Tukey’s compound covariate.- 4.3 Univariate selection.- 4.4 Meta-analytic data with high-dimensional covariates.- 4.5 The joint model with compound covariates .- 4.6 The joint model with ridge or Lasso predictor .- 4.7 Prediction of patient-level survival function .- 4.8 Simulations.- 4.8.1 Simulation design.- 4.8.2 Simulation results.- 4.9 Case study: ovarian cancer data .- 4.9.1 Compound covariate.- 4.9.2 Fitting the joint frailty-copula mode.- 4.9.3 Patient-level survival function.- 4.10 Concluding remarks.- References.- Chapter 5: Dynamic prediction of time-to-death.- 5.1 Accurate prediction of survival.- 5.2 Framework of dynamic prediction.- 5.2.1 Conditional failure function given tumour progression.- 5.2.2 Conditional hazard function given tumour progression.- 5.3 Prediction formulas under the joint frailty-copula model.- 5.4 Estimating prediction formulas.- 5.5 Case study: ovarian cancer data.- 5.6 Discussions.- References.- Chapter 6: Future developments- 6.1 Analysis of recurrent events.- 6.2 Kendall’s tau in meta-analysis.- 6.3 Validation of surrogate endpoints.- 6.4 Left-truncation.- 6.5 Interactions.- 6.6 Parametric failure time models.- 6.7 Compound covariate.- References.- Appendix A: Cubic spline bases.- Appendix B: R codes for the ovarian cancer data analysis.- B1. Using CXCL12 gene as a covariate.- B2. Using compound covariates (CCs) and residual tumour as covariates.- Appendix C: Derivation of prediction formulas.

“This book can be used as a textbook for a course aimed at postgraduate students in biostatistics and medicine.” (Denis Sidorov, zbMATH 1429.62003, 2020)

Erscheinungsdatum
Reihe/Serie JSS Research Series in Statistics
SpringerBriefs in Statistics
Zusatzinfo 19 Illustrations, color; 10 Illustrations, black and white; XVII, 118 p. 29 illus., 19 illus. in color.
Verlagsort Singapore
Sprache englisch
Maße 155 x 235 mm
Themenwelt Mathematik / Informatik Mathematik Wahrscheinlichkeit / Kombinatorik
Studium Querschnittsbereiche Epidemiologie / Med. Biometrie
Sozialwissenschaften Soziologie Empirische Sozialforschung
ISBN-10 981-13-3515-X / 981133515X
ISBN-13 978-981-13-3515-0 / 9789811335150
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
ein überfälliges Gespräch zu einer Pandemie, die nicht die letzte …

von Christian Drosten; Georg Mascolo

Buch | Hardcover (2024)
Ullstein Buchverlage
24,99

von Matthias Egger; Oliver Razum; Anita Rieder

Buch | Softcover (2021)
De Gruyter (Verlag)
59,95